Clinical performance of matrix metalloproteinases and inflammatory cytokines in differentiating active tuberculosis from latent tuberculosis infection
Frontiers in Cellular and Infection Microbiology · 18.11.2026 · 16
DOI: 10.3389/fcimb.2026.2001501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 18.11.2026. Verfasst von Mengyu Yang und 6 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Early differential diagnosis of active tuberculosis (TB) and latent tuberculosis infection (LTBI) is crucial for TB prevention and treatment. Both matrix metalloproteinases (MMPs) and inflammatory markers participate in TB-related inflammation, but their combined value in TB differentiation remain unclear. This study aimed to evaluate the analytical performance of the MAGLUMI MMP-1 and MMP-7 assays, and to explore the diagnostic value of MMP-1, MMP-7 combined with traditional inflammatory markers in distinguishing TB from LTBI. Study design We assessed the precision, linearity, limit of blank (LoB), limit of detection (LoD), limit of quantification (LoQ), interference and trueness of MAGLUMI MMP-1 and MMP-7 assays. We enrolled 146 subjects (39 healthy controls, 46 LTBI, 61 TB), detected their MMP-1, MMP-7 and inflammatory marker levels, and used Mann Whitney test, logistic regression and receiver operating characteristic (ROC) curve for statistical analysis.
Results
Both MAGLUMI MMP-1 and MMP-7 assays showed good precision, linearity and trueness. TB patients were older than LTBI subjects ( P = 0.008) with significantly higher rates of cough/sputum ( P < 0.001), chest pain ( P = 0.030) and characteristic imaging findings (cavitation, focal consolidation, reticular interstitial pattern: P < 0.001). MMP-1, CRP, SAA, IL-6, and PCT were significantly higher in TB (MMP-1: P = 0.045; others: P < 0.001) compared to LTBI, while no significant differences were found in MMP-7 and TNF-α. Among the single markers, CRP (AUC = 0.802, 95% confidence interval (CI): 0.720-0.884) had the higher diagnostic efficacy, and the combination of age, CRP, SAA, IL-6 and PCT had the highest AUC of 0.899 (95% CI: 0.841-0.956), with a sensitivity of 89% and a specificity of 80%. However, the addition of MMP-1 did not improve the discriminative ability of the combined model.
Conclusions
MAGLUMI MMP-1 and MMP-7 assays have reliable analytical performance. Age, CRP, SAA, IL-6, and PCT are valuable for differentiating TB from LTBI, and their combination enhances diagnostic efficacy. However, increasing MMP-1 or 7 does not improve the differential diagnostic performance of the above model, even though there are differences in MMP-1 between groups.
Zitieren
APA
Yang, M., Zhang, H., Chen, C., Wei, Z., Li, W., Fang, Z., & Xu, Y. (2026). Clinical performance of matrix metalloproteinases and inflammatory cytokines in differentiating active tuberculosis from latent tuberculosis infection. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.2001501
Vancouver
Yang M, Zhang H, Chen C, Wei Z, Li W, Fang Z, et al. Clinical performance of matrix metalloproteinases and inflammatory cytokines in differentiating active tuberculosis from latent tuberculosis infection. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.2001501
BibTeX
@article{Yang2026,
author = {Yang, Mengyu and Zhang, Hongwei and Chen, Chan and Wei, Zimei and Li, Weiting and Fang, Zhonggang and Xu, Yuzhong},
title = {Clinical performance of matrix metalloproteinases and inflammatory cytokines in differentiating active tuberculosis from latent tuberculosis infection},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.2001501}
}
EUVIMED